全文获取类型
收费全文 | 774篇 |
免费 | 41篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 28篇 |
妇产科学 | 7篇 |
基础医学 | 44篇 |
口腔科学 | 26篇 |
临床医学 | 149篇 |
内科学 | 146篇 |
皮肤病学 | 2篇 |
神经病学 | 10篇 |
特种医学 | 163篇 |
外科学 | 141篇 |
综合类 | 25篇 |
预防医学 | 33篇 |
药学 | 23篇 |
肿瘤学 | 36篇 |
出版年
2023年 | 6篇 |
2022年 | 2篇 |
2021年 | 11篇 |
2020年 | 2篇 |
2019年 | 5篇 |
2018年 | 6篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 5篇 |
2014年 | 18篇 |
2013年 | 34篇 |
2012年 | 14篇 |
2011年 | 28篇 |
2010年 | 26篇 |
2009年 | 48篇 |
2008年 | 33篇 |
2007年 | 23篇 |
2006年 | 21篇 |
2005年 | 19篇 |
2004年 | 15篇 |
2003年 | 23篇 |
2002年 | 27篇 |
2001年 | 17篇 |
2000年 | 14篇 |
1999年 | 11篇 |
1998年 | 41篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 35篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 8篇 |
1989年 | 25篇 |
1988年 | 24篇 |
1987年 | 16篇 |
1986年 | 9篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1982年 | 19篇 |
1981年 | 12篇 |
1980年 | 17篇 |
1979年 | 2篇 |
1978年 | 9篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1975年 | 2篇 |
1972年 | 1篇 |
排序方式: 共有835条查询结果,搜索用时 250 毫秒
701.
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation 总被引:1,自引:0,他引:1
Molrine DC; Guinan EC; Antin JH; Parsons SK; Weinstein HJ; Wheeler C; McGarigle C; Blanding P; Phillips NR; Kinsella K; Deans K; Ciamarra A; Goorin A; George S; Ambrosino DM 《Blood》1996,87(7):3012-3018
Bone marrow transplant patients are at increased risk for infections with polysaccharide encapsulated organisms and respond poorly to polysaccharide vaccines. We evaluated the effect of donor immunization with Haemophilus influenzae type b (HIB) polysaccharide-conjugate vaccine on recipient antibody responses following allogeneic bone marrow transplantation. Thirty-two allogeneic transplant patients and their donors were immunized before transplantation with HIB-conjugate, tetanus toxoid and 23-valent pneumococcal vaccines. Following transplantation, patients received HIB-conjugate and tetanus toxoid vaccines at 3, 6, 12, and 24 months and 23-valent pneumococcal vaccine at 12 and 24 months. Thirty-three patients with unimmunized donors were immunized following transplantation in an identical manner. Patients whose donors were immunized had significantly higher total anti-HIB antibody concentrations at 3 months (P = .0001), 6 months (P = .0001), 12 months (P = .0001), and 24 months (P = .002) after transplant compared with patients whose donors were unimmunized. Higher antitetanus toxoid antibody concentrations were also noted in patients with immunized donors, whereas donor immunization with pneumococcal vaccine had no effect on antibody concentrations following transplantation. Donor immunization with HIB-conjugate vaccine resulted in higher antibody concentrations in patients as early as 3 months after allogeneic transplantation and may be an effective strategy to prevent HIB infections. 相似文献
702.
703.
Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice 总被引:3,自引:1,他引:3
Boland EJ; Liu YC; Walter CA; Herbert DC; Weaker FJ; Odom MW; Jagadeeswaran P 《Blood》1995,86(6):2198-2205
Factor IX (FIX), a circulating serine protease that serves as an essential component of the blood coagulation pathway, has been shown to increase with age in humans. We show here that murine FIX mRNA and activity levels also increase with age. Furthermore, one form of hemophilia B, hemophilia B Leyden, which is caused by mutations within the promoter region of the FIX gene, has a distinct age-dependent phenotype. To determine the source of the age-related increases in FIX gene expression, we have analyzed the regulation of the normal FIX gene promoter and FIX Leyden gene promoter with the +13 mutation during aging by generating transgenic mice that contain the -189 to +21 bp promoter segment ligated to a chloramphenicol acetyltransferase reporter gene. We have established that the normal FIX promoter and the Leyden promoter transgenes are expressed in a tissue-specific manner in vivo. The normal FIX promoter transgene does not show any differences in the pattern of expression with age or sex of the organism, whereas the Leyden promoter transgene showed age-dependent male-specific expression. This is the first demonstration of the FIX Leyden phenotype in a transgenic mouse model. 相似文献
704.
We describe a simple test for direct or indrect detection of antineutrophil antibodies. Sensitized leukocytes adherent to glass slides and fixed with paraformaldehyde can be stored in buffer for at least 3 wk. Killed Cowan I staphylococci, containing protein A, bind to sensitized but not control cells, and binding is ascertainable by light microscopy. Indirect tests were positive for 39/41 patients suspected of having immune neutropenia and found to have antineutrophil antibodies by an indirect radiochemical opsonic method. Fifty-four control sera from healthy persons, patients with bone marrow failure, or with immune complex diseases without neutropenia, gave negative indirect tests. Direct tests for cell-bound antibody could be done even during severe neutropenia by reacting fixed autologous cells with staphylococci in the absence of added serum. In some patients only the direct test was positive. 相似文献
705.
Gregory G. Polkowski MD Ryan M. Nunley MD Erin L. Ruh MS Brandon M. Williams DC Robert L. Barrack MD 《Clinical orthopaedics and related research》2012,470(11):2988-2994
Background
Avoiding complications after hip arthroplasty with hard-on-hard bearings, especially metal-on-metal, correlates with the position of the acetabular component. Supine imaging with conventional radiography has traditionally been utilized to assess component inclination (abduction), as well as anteversion, after THA and surface replacement arthroplasty (SRA). However, most adverse events with hard bearings (excessive wear and squeaking) have occurred with loading. Standing imaging, therefore, should provide more appropriate measurements. 相似文献706.
François Nougarou PhD Claude Dugas Michel LorangerIsabelle Pagé DC Martin Descarreaux 《Journal of manipulative and physiological therapeutics》2014
Objectives
Previous studies have identified preload forces and an important feature of skillful execution of spinal manipulative therapy (SMT) as performed by manual therapists (eg, doctors of chiropractic and osteopathy). It has been suggested that applying a gradual force before the thrust increases the spinal unit stiffness, minimizing displacement during the thrust. Therefore, the main objective of this study was to assess the vertebral unit biomechanical and neuromuscular responses to a graded increase of preload forces.Methods
Twenty-three participants underwent 4 different SMT force-time profiles delivered by a servo-controlled linear actuator motor and varying in their preload forces, respectively, set to 5, 50, 95, and 140 N in 1 experimental session. Kinematic markers were place on T6, T7, and T8 and electromyographic electrodes were applied over paraspinal muscles on both sides of the spine.Results
Increasing preload forces led to an increase in neuromuscular responses of thoracic paraspinal muscles and vertebral segmental displacements during the preload phase of SMT. Increasing the preload force also yielded a significant decrease in sagittal vertebral displacement and paraspinal muscle activity during and immediately after the thrust phase of spinal manipulation. Changes observed during the SMT thrust phase could be explained by the proportional increase in preload force or the related changes in rate of force application. Although only healthy participants were tested in this study, preload forces may be an important parameter underlying SMT mechanism of action. Future studies should investigate the clinical implications of varying SMT dosages.Conclusion
The present results suggest that neuromuscular and biomechanical responses to SMT may be modulated by preload through changes in the rate of force application. Overall, the present results suggest that preload and rate of force application may be important parameters underlying SMT mechanism of action. 相似文献707.
708.
709.
710.
DC Crawford 《Journal of medical engineering & technology》2013,37(3):108-111
The evaluation of medical devices in the UK has been through many changes since the early hospital equipment assessments in the 1960s. The range of medical devices evaluated has increased and the evaluation reports published have changed, but the evaluation programme continues to be a respected service for the NHS and social care. This review documents the history of the Device Evaluation Service, from its beginnings to the present day, and looks forward to its future. Following an independent strategic review and the Healthcare Industries Task Force (HITF) recommendations, the Device Evaluation Service is now entering a new and exciting developmental phase. 相似文献